An experimental drug developed with the help of artificial intelligence (AI) has shown early signs that it could reduce markers of biological ageing while treating idiopathic pulmonary fibrosis (IPF), ...

Insilico Medicine ("Insilico"), a clinical-stage company focused on generative AI-driven drug discovery and development, ...

This listicle highlights real-world success stories in drug repurposing and emerging strategies involving genomics, clinical ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The premise is straightforward — we are awash in biological data. The rapid growth of multiomics datasets (genomics, transcriptomics, proteomics, metabolomics, and radiomics) together with ...

When a drug fails a clinical trial, it may seem that years of research and development have gone to waste. A failed trial, ...

NEW YORK--(BUSINESS WIRE)--The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New York City, unveiling advances that mark a pivotal ...

Curative Biotechnology, founded by Paul Michaels, is one example of a company building its research model around that ...

The US Food and Drug Administration (FDA) is asking for input on repurposing older drugs for new therapeutic uses to address unmet medical needs across a wide range of therapeutic areas. FDA said that ...

The U.S. Food and Drug Administration (FDA) recently launched a drug repurposing initiative that may signal a shift in how the Agency approaches therapeutic development. Rather than focusing ...